Flagship Biosciences delivers comprehensive tissue profiling using our Artificial Intelligence (AI) enabled cTA® pathology platform.
Flagship Biosciences has raised $5.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2024.
Flagship Biosciences is headquartered in Westminster, United States.
Flagship Biosciences delivers comprehensive tissue profiling using our Artificial Intelligence (AI) enabled cTA® pathology platform.
Flagship Biosciences is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Flagship Biosciences — Funding & Investors." VCBacked, April 16, 2024, https://www.vcbacked.co/company/flagship-biosciences. Accessed November 13, 2026.
VCBacked. (2024). Flagship Biosciences — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/flagship-biosciences
{{cite web |title=Flagship Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/flagship-biosciences |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Flagship Biosciences? Request a listing update